It is a drug that is used to modify the symptoms of Multiple Sclerosis disease, MS, remitting and active, which is when a component of the body does not work as it should and hardens the tissues, increasing their size, affecting the blood vessels and the nervous system central. The component of Gilenya is Fingolimod in a 0.5 mg tablet form.
The recommended dose is a daily pill, that is, a single dose a day, which must be under medical supervision when starting treatment since the pill tends to lower the heart rate, for this reason, blood pressure must be controlled before, during and after the first feeding, in a process of evaluating the pressure every hour for six hours in a row.
The primary qualities of this treatment is to limit the lymphocytes, (a type of white blood cells) preventing them from moving through the blood, the asset that causes MS to go down from the lymph nodes to the brain and spinal cord, blocking the receptor and regulating its action of displacement of cells that carry MS to the body, it is known as T lymphocyte or Sphingosine-1-Phosphate receptor.
Side effects demonstrated in clinical studies range from headache, body discomfort, flu in any of its forms of discomfort, localized pain such as in the back, chest, feet, hands or arms, rash or blisters on the skin, discomfort stomach problems such as diarrhea, bitter taste in the mouth, dry cough. Among the most serious are infections, visual impairment, low heart rate, fainting and confusion, seizures, respiratory distress, among others.
Patients who should not do this type of treatment are those who suffer from frequent infections that have to do with the immune system, where the body is weakened with each infection or those who suffer from hepatitis, women who plan to get pregnant or who already They are, people who suffer from the heart or who have another type of treatment for this, those who have a history of heart attacks and cerebral blood supply.
